⏳ Fetching live dividend data...
Home › Calculator › ISCO Dividend Calculator 2026
International Stem Cell Corporation · OTC
Price: $0.17 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in ISCO → $1306300.50M in 10 years · $70,911,257,459.00/month
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; and develops, manufactures, and markets anti-aging skincare and human cell culture products. The company's human cell culture products include human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines for the study of breast cancer, three dimensional culture, and carcinogen screening. Its human cell culture products also comprise adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; human female reproductive system cells for the study of cellular physiology; human skeletal muscle cells for the study of biology, diabetes, insulin receptor studies, muscle metabolism, muscle tissue repair, and myotube development; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. The company sells skincare products through a website and professional channels; and human cell culture products through its sales force, OEM partners, and brand distributors. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ISCO position with:
Real after-tax yield depends on where you live and how you hold ISCO.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1176.47% | 1173.67% | $117,647 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1000.00% | 997.20% | $100,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 941.18% | 938.38% | $94,118 / yr |
| 🇬🇧 UK ISA | 0% | 1176.47% | 1173.67% | $117,647 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1073.53% | 1070.73% | $107,353 / yr |
| 🇨🇦 TFSA | 0% | 1176.47% | 1173.67% | $117,647 / yr |
| 🇨🇦 CA Taxable | 25% | 882.35% | 879.55% | $88,235 / yr |
| 🇦🇺 Super (pension) | 15% | 1000.00% | 997.20% | $100,000 / yr |
| 🇦🇺 AU Taxable | 30% | 823.53% | 820.73% | $82,353 / yr |
| 🇩🇪 DE Taxable | 26.375% | 866.18% | 863.38% | $86,618 / yr |
| 🇫🇷 FR Taxable | 30% | 823.53% | 820.73% | $82,353 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
ISCO pays quarterly — 4 times per year. Next ex-div: TBD.
How ISCO compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ISCO sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2025-06-17 | 532,786 | $0.13 | $69.3K | ||
| A-Award | 2025-06-17 | 30,000 | $0.13 | $3.9K | ||
| A-Award | 2023-11-06 | 500,000 | $0.12 | $60.0K | ||
| A-Award | 2023-11-06 | 2,000,000 | $0.12 | $240.0K | ||
| A-Award | 2023-06-14 | 445,205 | $0.14 | $62.3K | ||
| A-Award | 2023-06-14 | 30,000 | $0.14 | $4.2K | ||
| A-Award | 2023-06-14 | 445,205 | $0.14 | $62.3K | ||
| A-Award | 2023-06-14 | 30,000 | $0.14 | $4.2K | ||
| A-Award | 2023-06-14 | 500,000 | $0.14 | $70.0K | ||
| A-Award | 2021-06-09 | 250,000 | $0.39 | $97.5K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ISCO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →